NanoString Technologies has hired Lianne McLean as vice president of marketing in preparation for the commercial launch of the nCounter Analysis System.
McLean joined NanoString from Applied Biosystems where she served as director of global strategic marketing in the molecular cell biology division.
Prior to Applied Biosystems, McLean spent six years at Affymetrix where she played a role in bringing whole genome expression arrays to market, building a supporting reagents business, and developing the custom and model organism array program. McLean also spent five years at Roche Molecular Diagnostics and Chiron Diagnostics marketing in vitro diagnostics tests for infectious diseases.
Rules Based Medicine this week said that Matt Zell, managing director of Equity Group Investments, has joined its board of directors in conjunction with a $25 million financing round (see related story, this issue).